Synapse - Myeloma

Search Within

Myeloma

Results (990)

Maintained hematologic and organ responses following risk adapted stem cell transplant (SCT) in systemic light-chain amyloidosis (AL) using bortezomib and dexamethasone as consolidation therapy

Meeting Abstract

Landau, H. J.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Comenzo, R. L.
Biology of Blood and Marrow Transplantation (2012)

Fulltext@MSK | Save

Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease

Journal Article

Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
Leukemia and Lymphoma (2012)

Fulltext@MSK | Save

Patterns of disease relapse and progression in patients with multiple myeloma after first line therapy with autologous stem cell transplantation: Implications for patient monitoring after transplantation

Meeting Abstract

Zamarin, D.; Bhutani, M.; Chimento, D.; Giralt, S.; Lendvai, N.; Landau, H.; Lesokhin, A.; Chung, D.; Babu, D.; Hassoun, H.
Blood (2011)

Fulltext@MSK | Save

Monocytic CCR2+myeloid derived suppressor cells promote immune escape by limiting activated CD8 T cell infiltration into the tumor microenvironment

Meeting Abstract

Lesokhin, A.; Hohl, T.; Merghoub, T.; Hirschhorn-Cymerman, D.; Pamer, E. G.; Houghton, A. N.; Wolchok, J. D.
Blood (2011)

Fulltext@MSK | Save

Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis

Meeting Abstract

Landau, H.; Hassoun, H.; Hoffman, J. E.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P. S.; Comenzo, R. L.
Blood (2011)

Fulltext@MSK | Save

T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics

Meeting Abstract

Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M. A.; Heller, G.; Giralt, S.
Blood (2011)

Fulltext@MSK | Save

Cost analysis of using plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients treated at Memorial Sloan-Kettering Cancer Center (MSKCC)

Meeting Abstract

Adel, N. G.; Duck, E.; Collum, K.; Mccullagh, E.; Reich, L.; Landau, H.; Giralt, S.; Hassoun, H.
Blood (2011)

Fulltext@MSK | Save

Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: Cardiac responses and overall effects

Journal Article

Dubrey, S. W.; Reece, D. E.; Sanchorawala, V.; Hegenbart, U.; Merlini, G.; Palladini, G.; Fermand, J. P.; Vescio, R. A.; Blade, J.; Heffner, L. T.; more...
QJM: An International Journal of Medicine (2011)

Fulltext@MSK | Save

Hiding the road signs that lead to tumor immunity

Journal Article

Schaer, D. A.; Lesokhin, A. M.; Wolchok, J. D.
Journal of Experimental Medicine (2011)

Fulltext@MSK | Save

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: Results of a phase 1/2 study

Journal Article

Reece, D. E.; Hegenbart, U.; Sanchorawala, V.; Merlini, G.; Palladini, G.; Blade, J.; Fermand, J. P.; Hassoun, H.; Heffner, L.; Vescio, R. A.; more...
Blood (2011)

Fulltext@MSK | Save